Abstract:The use of immune checkpoint inhibitors (ICIs) has represented a major advance in cancer treatment. By enhancing endogenous immune responses to destroy cancer cells, ICIs can cause immune-related adverse events (irAEs), with possible involvement of any organ system. IrAEs are frequent, particularly those involving the skin or the endocrine system, and usually completely reversible after temporary immunosuppression, while neurological irAEs (n-irAEs) are relatively rare, often severe, and they carry a considerable risk of mortality and long-term disability. They usually affect the peripheral nervous system, mainly manifesting as myositis, polyradiculoneuropathy, or cranial neuropathy, and, less frequently, involve the central nervous system, causing encephalitis, meningitis, or myelitis. Although somehow reminiscent of the disorders that neurologists are familiar to deal with in their daily practice, n-irAEs are characterized by distinctive features from their idiopathic counterparts; for instance, myositis may have a predominant oculo-bulbar involvement reminiscent of myasthenia gravis and frequently associates with myocarditis; peripheral neuropathy, although often resembling Guillain-Barré syndrome, usually responds to corticosteroids. Remarkably, several associations between the neurological phenotype and the type of ICIs or the type of cancer have emerged in the last few years, and the growing administration of ICIs in patients with neuroendocrine cancers has led to an increased number of reports of paraneoplastic neurological syndromes (triggered or worsened by ICIs). This review aims to update current knowledge regarding the clinical presentation of n-irAEs. We also discuss the essential parts of the diagnostic approach, and we provide general recommendations for the management of these disorders.

Autoimmune and inflammatory neurological disorders in the intensive care unit

Pediatric Neuroinflammatory Diseases in the Intensive Care Unit

Autoimmune Encephalitis: Insights Into Immune-Mediated Central Nervous System Injury

Acute encephalopathy in the ICU: a practical approach

A clinical approach to diagnosis of autoimmune encephalitis

Characterization and prognosis of autoimmune encephalitis in the neurological intensive care unit: a retrospective study

Navigating the diagnostic and therapeutic complexities of autoimmune encephalitis

Immune therapy in autoimmune encephalitis: a systematic review

Overview and Diagnostic Approach in Autoimmune Neurology

Intensive care management of patients with viral encephalitis

Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review

Infection or Inflammation and Critical Care Seizures

Autoimmune encephalitis: what the radiologist needs to know

Treatment strategies for autoimmune encephalitis

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment

Neurological adverse events of immune checkpoint inhibitors: An update of clinical presentations, diagnosis, and management

Clinical Approach and Prognosis of Continuous Neurological Care after Intensive Care for the Patients with Severe and Refractory Anti-N-methyl-d-aspartate Receptor Encephalitis

Encephalitis: diagnosis, management and recent advances in the field of encephalitides

ICU delirium - a diagnostic and therapeutic challenge in the intensive care unit.

How to manage catatonia, Parkinson and dementia in ICU